...
首页> 外文期刊>Cancer immunology research. >LncRNA-MM2P Identified as a Modulator of Macrophage M2 Polarization
【24h】

LncRNA-MM2P Identified as a Modulator of Macrophage M2 Polarization

机译:LNCRNA-MM2P鉴定为巨噬细胞M2极化的调节剂

获取原文
获取原文并翻译 | 示例
           

摘要

M2 polarization of macrophages is essential for their function in immunologic tolerance, which might promote tumorigenesis. However, the molecular mechanism behind the polarization process is not fully understood. Given that several lines of evidence have suggested that long noncoding RNAs (lncRNAs) could be involved in regulating immune cell differentiation and function, the current study aimed to identify the lncRNAs that specifically modulate M2 macrophage polarization. By utilizing a series of cell-based M2 macrophage polarization models, a total of 25 lncRNAs with altered expression were documented based on lncRNA microarray-based profiling assays. Among them, lncRNA-MM2P was the only lncRNA upregulated during M2 polarization but downregulated in M1 macrophages. Knockdown of lncRNA-MM2P blocked cytokine-driven M2 polarization of macrophages and weakened the angiogenesis- promoting feature of M2 macrophages by reducing phosphorylation on STAT6. Moreover, manipulating lncRNA-MM2P in macrophages impaired macrophage-mediated promotion of tumorigenesis, tumor growth in vivo, and tumor angiogenesis. Collectively, our study identifies lncRNA-MM2P as a modulator required for macrophage M2 polarization and uncovers its role in macrophage-promoted tumorigenesis.
机译:M2巨噬细胞的偏振对于它们在免疫耐受性中的功能至关重要,这可能促进肿瘤发生。然而,偏振过程背后的分子机制尚不完全理解。鉴于几种证据表明,目前的研究旨在涉及调节免疫细胞分化和功能的长度非编码RNA(LNCRNA),旨在鉴定特异性调节M2巨噬细胞极化的LNCRNA。通过利用一系列基于细胞的M2巨噬细胞偏振模型,基于基于LNCRNA微阵列的分析测定,记录了总共25个具有改变的表达的LNCRNA。其中,LNCRNA-MM2P是在M2偏振期间仅上调的唯一LNCRNA,但在M1巨噬细胞中下调。 LNCRNA-MM2P的敲低阻断细胞因子驱动的M2巨噬细胞偏振,通过减少Stat6上的磷酸化而削弱了M2巨噬细胞的血管生成促进特征。此外,在巨噬细胞中操纵LNCRNA-MM2P受损的巨噬细胞介导的肿瘤发生,体内肿瘤生长和肿瘤血管生成。一致性地,我们的研究将LNCRNA-MM2P识别为巨噬细胞M2偏振所需的调节剂,并在巨噬细胞促进的肿瘤发生中揭示其作用。

著录项

  • 来源
    《Cancer immunology research.》 |2019年第2期|共14页
  • 作者单位

    Zhejiang Univ Coll Pharmaceut Sci Inst Pharmacol &

    Toxicol Zhejiang Prov Key Lab Anticanc Drug;

    Zhejiang Univ Coll Pharmaceut Sci Inst Pharmacol &

    Toxicol Zhejiang Prov Key Lab Anticanc Drug;

    Zhejiang Univ Coll Pharmaceut Sci Inst Pharmacol &

    Toxicol Zhejiang Prov Key Lab Anticanc Drug;

    Zhejiang Univ Coll Pharmaceut Sci Inst Pharmacol &

    Toxicol Zhejiang Prov Key Lab Anticanc Drug;

    Zhejiang Univ Coll Pharmaceut Sci Inst Pharmacol &

    Toxicol Zhejiang Prov Key Lab Anticanc Drug;

    Zhejiang Univ Coll Pharmaceut Sci Inst Pharmacol &

    Toxicol Zhejiang Prov Key Lab Anticanc Drug;

    Zhejiang Univ Sch Med Affiliated Hangzhou Peoples Hosp 1 Hangzhou Zhejiang Peoples R China;

    Tongde Hosp Zhejiang Prov Hangzhou Zhejiang Peoples R China;

    Zhejiang Univ Affiliated Hosp 2 Dept Orthoped Hangzhou Zhejiang Peoples R China;

    Zhejiang Univ Coll Pharmaceut Sci Inst Pharmacol &

    Toxicol Zhejiang Prov Key Lab Anticanc Drug;

    Zhejiang Univ Coll Pharmaceut Sci Inst Pharmacol &

    Toxicol Zhejiang Prov Key Lab Anticanc Drug;

    Zhejiang Univ Coll Pharmaceut Sci Inst Pharmacol &

    Toxicol Zhejiang Prov Key Lab Anticanc Drug;

    Zhejiang Univ Coll Pharmaceut Sci Inst Pharmacol &

    Toxicol Zhejiang Prov Key Lab Anticanc Drug;

    Zhejiang Univ Coll Pharmaceut Sci Inst Pharmacol &

    Toxicol Zhejiang Prov Key Lab Anticanc Drug;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号